Toggle navigation
COVID-19
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
ASCO20 Virtual Scientific Program
AACR Virtual Meeting: COVID-19 and Cancer
AACR Virtual Annual Meeting 2020 II
EHA25 Virtual
First International Summit on Interventional Pharmacoeconomics
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
View All
Videos
Newsreels
Roundtable:
Lymphoma/Myeloma
Roundtable:
Lung Cancer
Podcasts
CME
Methotrexate–Induced Kidney Injury
Advertisement
Conquer Cancer Foundation
November 10, 2018
Advertisement
Advertisement
Advertisement
Aug
07
Today In Oncology
ESMO World GI: Third- or Later-Line Treatment With Infigratinib in Patients With Cholangiocarcinoma and FGR2 Fusions
Phase IB Trial of Atezolizumab With or Without Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma
Refinement of European LeukemiaNet Classification Recommendations for Younger Patients With AML
ESMO Issues Consensus on the Management of Patients With Cancer During the COVID-19 Pandemic
Pan-BET Bromodomain Inhibitor Plus Enzalutamide in Advanced Prostate Cancer
View More
Advertisement
